• 2019 Aria Care Pathways For Allergen Immunotherapy 

      Bousquet, Jean; Pfaar, Oliver; Togias, Alkis; Schuenemann, Holger J.; Ansotegui, Ignacio; Papadopoulos, Nikolaos G.; Tsiligianni, Ioanna; Agache, Ioana; Anto, Josep M.; Bachert, Claus; Bedbrook, Anna; Bergmann, Karl-Christian; Bosnic-Anticevich, Sinthia; Bosse, Isabelle; Brozek, Jan; Calderon, Moises A.; Canonica, Giorgio W.; Caraballo, Luigi; Cardona, Victoria; Casale, Thomas; Cecchi, Lorenzo; Chu, Derek; Costa, Elisio; Cruz, Alvaro A.; Czarlewski, Wienczyslawa; Durham, Stephen R.; Du Toit, George; Dykewicz, Mark; Ebisawa, Motohiro; Fauquert, Jean Luc; Fernandez-Rivas, Montserrat; Fokkens, Wytske J.; Fonseca, Joao; Fontaine, Jean-Francois; van Wijk, Roy Gerth; Haahtela, Tari; Halken, Susanne; Hellings, Peter W.; Ierodiakonou, Despo; Iinuma, Tomohisa; Carlos Ivancevich, Juan; Jacobsen, Lars; Jute, Marek; Kaidashev, Igor; Khaitov, Musa; Kalayci, Omer; Tebbe, Joerg Kleine; Klimek, Ludger; Kowalski, Marek L.; Kuna, Piotr; Kvedariene, Violeta; La Grutta, Stefania; Larenas-Linemann, Desiree; Lau, Susanne; Laune, Daniel; Le, Lan; Carlsen, Karin Lodrup; Lourenco, Olga; Malling, Hans-Jorgen; Marien, Gert; Menditto, Enrica; Mercier, Gregoire; Mullol, Joaquim; Muraro, Antonella; O'Hehir, Robyn; Okamoto, Yoshitaka; Pajno, Giovanni B.; Park, Hae-Sim; Panzner, Petr; Passalacqua, Giovanni; Pham-Thi, Nhan; Roberts, Graham; Pawankar, Ruby; Rolland, Christine; Rosario, Nelson; Ryan, Dermot; Samolinski, Boleslaw; Sanchez-Borges, Mario; Scadding, Glenis; Shamji, Mohamed H.; Sheikh, Aziz; Sturm, Gunter J.; Bom, Ana Todo; Toppila-Salmi, Sanna; Valentin-Rostan, Maryline; Valiulis, Arunas; Valovirta, Erkka; Ventura, Maria-Teresa; Wahn, Ulrich; Walker, Samantha; Wallace, Dana; Waserman, Susan; Yorgancioglu, Arzu; Zuberbier, Torsten; Grp, ARIA Working (2019)
      Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced but the evidence-based method varies, ...
    • Challenges And Choices In The Pharmacological Treatment Of Non-Severe Pediatric Asthma: A Commentary For The Practicing Physician 

      Kalayci, Omer; Abdelateef, Hanan; Pozo Beltrán, César Fireth; El-Sayed, Zeinab A.; Gómez, René Maximiliano; Hossny, Elham; Morais-Almeida, Mário; Nieto, Antonio; Phipatanakul, Wanda; Pitrez, Paulo; Wong, Gary Wk.; Xepapadaki, Paraskevi; Papadopoulos, Nikolaos G. (2019)
      In recent years, asthma research has focused intensely on the severe part of the disease spectrum, leading to new treatments, mostly therapeutic monoclonal antibodies. However, severe asthma accounts for not more than 2% ...
    • Eaaci Guidelines On Allergen Immunotherapy: House Dust Mite-Driven Allergic Asthma 

      Agache, Ioana; Lau, Susanne; Akdis, Cezmi A.; Smolinska, Sylwia; Bonini, Matteo; Cavkaytar, Ozlem; Flood, Breda; Gajdanowicz, Pawe; Izuhara, Kenji; Kalayci, Omer; Mosges, Ralph; Palomares, Oscar; Papadopoulos, Nikolaos G.; Sokolowska, Milena; Angier, Elisabeth; Fernandez-Rivas, Montserrat; Pajno, Giovanni; Pfaar, Oliver; Roberts, Graham C.; Ryan, Dermot; Sturm, Gunter J.; van Ree, Ronald; Varga, Eva M.; van Wijk, Roy Gerth; Yepes-Nunez, Juan Jose; Jutel, Marek (2019)
      Allergen immunotherapy (AIT) has been in use for the treatment of allergic disease for more than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers recommended to achieve and maintain asthma ...